Comment on “Dexamethasone-sparing on days 2–4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)”

British Journal of Cancer, Published online: 26 February 2024; doi:10.1038/s41416-024-02611-zComment on “Dexamethasone-sparing on days 2–4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)”

https://www.nature.com/articles/s41416-024-02611-z

Source: British Journal of Cancer - February 26, 2024 Category: Cancer & Oncology Authors: Luigi Celio Andrea Antonuzzo Matti S. Aapro Source Type: research